logo

For the Inventor, By the Inventor

Moscow, Russia

Ludmila Pavlova

This inventor holds 17 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignees: Renaltech International, LLC, Cytosorbents Corporation, Medasorb Corporation. Active years: 2000-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ludmila Pavlova. Retrieved from https://idiyas.com/inventor/ludmila-pavlova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 70.6


Average Co-Inventor Count = 4.4

ph-index = 11

Forward Citations = 302(Granted Patents)


Company Filing History:

goldMedal12 out of 21 
 
Renaltech International, LLC
 patents
silverMedal4 out of 30 
 
Cytosorbents Corporation
 patents
bronzeMedal1 out of 3 
 
Medasorb Corporation
 patents
4. 5 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 2000-2013

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents
1. 8349550 - Methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood (2013-01-08),
2. 8334094 - Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood products (2012-12-18),
3. 8329388 - Biocompatible devices, systems, and methods for reducing levels of proinflammatory of antiinflammatory stimulators or mediators in the blood (2012-12-11),
4. 7846650 - Methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood (2010-12-07),
5. 7556768 - Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood (2009-07-07),
6. 7312023 - Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processing (2007-12-25),
7. 6878127 - Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood (2005-04-12),
8. 6531523 - Method of making biocompatible polymeric adsorbing material for purification of physiological fluids of organism (2003-03-11),
9. 6159377 - Method of purification of physiological liquids of organism (2000-12-11),
10. 615937 - Method of purification of physiological liquids of organism (2000-12-12),
11. 6156851 - Material for purification of physiological liquids of organism (2000-12-05),
12. 6153707 - Method of producing material for purification of physiological liquids (2000-11-28),
13. 6136424 - Method of and material for purification of physiological liquids of (2000-10-24),
14. 6133393 - Method of purification of physiological liquids of organism (2000-10-17),
15. 6127311 - Method of producing material for purification of physiological liquids (2000-10-03),

Title: Ludmila Pavlova: Innovator in Blood Mediator Reduction Technologies

Introduction

Ludmila Pavlova is a prominent inventor based in Moscow, Russia, known for her significant contributions to medical technology. With a total of 17 patents to her name, she has focused her research on methods and devices aimed at reducing pro-inflammatory and anti-inflammatory mediators in the blood. Her work addresses critical health issues related to inflammation and its associated diseases.

Latest Patents

Ludmila's latest patents include innovative methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood. These devices, systems, and methods utilize selective adsorption to effectively manage abnormal levels of these mediators. They are particularly useful in situations where excessive interaction among these stimulators occurs, or during events that may induce abnormal production. The primary goal of her inventions is to prevent, control, reduce, or alleviate the severity of inflammatory responses and related disease states.

Another notable patent focuses on reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood products. Similar to her previous work, these devices and methods aim to address the challenges posed by unregulated or excessive interactions among these mediators. The impact of her inventions is significant in the medical field, as they contribute to better management of inflammatory conditions.

Career Highlights

Throughout her career, Ludmila has worked with various organizations, including Renaltech

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…